Holtec Nuclear filed to raise up to $900 million at a $10.2 billion valuation under ticker HNUC โ then postponed the entire offering in mid-September 2026, just days before it was set to price.
The Camden, New Jersey-based nuclear services and small modular reactor developer had, according to Axios and Yahoo Finance's coverage of the filing, been positioned as one of the largest IPOs of the fall. Here is what the S-1 actually discloses, exactly why Holtec pulled the deal, and how it fits alongside 2026's other nuclear IPOs.

What Holtec Actually Does
Holtec is a nuclear services and technology company, holding more than 200 granted patents as of June 30, 2026 and operating three US manufacturing facilities, according to its S-1 filed with the SEC on July 10, 2026. The company has supplied products and services to more than 150 nuclear reactors worldwide, spanning spent-fuel storage and handling, decommissioning, and plant components โ the established, cash-generating side of the business.
The growth story investors were being pitched sits elsewhere: Holtec is developing the SMR-300, a small modular reactor design, with plans to deploy the first two units at its Palisades site in Michigan. Per the filing, that project includes recommissioning the Palisades nuclear plant itself, which the company describes as the first commercial reactor in US history to return to operation after a permanent shutdown โ a genuine industry first, not yet independently verified by a completed restart as of this writing.
The Deal Terms Holtec Filed
Holtec's amended S-1 set concrete pricing terms: 50 million shares of Class A common stock offered at $15 to $18 each, which would have raised up to $900 million and valued the company at up to $10.2 billion, according to Axios's reporting on the filing. The company planned to list on the Nasdaq Global Select Market and Nasdaq Texas under the ticker HNUC, with pricing expected around September 18-19, 2026.
That timeline never happened. In the days before the planned pricing, Holtec told bankers and reporters it was postponing the offering โ per Bloomberg's reporting, one of the largest nuclear-sector IPOs of 2026 pulled at the last moment.
Why the IPO Got Postponed
Per the Philadelphia Inquirer's reporting, Holtec spokesperson Patrick O'Brien attributed the delay to "market conditions," while founder and CEO Krishna P. Singh pointed specifically to uncertainty in power demand from US data centers โ the same AI-driven electricity-demand narrative that has powered nuclear and SMR valuations for the past two years suddenly became a source of doubt rather than confidence.
The aftermarket performance of 2026's earlier nuclear IPOs is the more concrete backdrop. Standard Nuclear's stock has traded well below its own IPO price since listing, and X-Energy was down roughly 37% from its April 2026 IPO price at the time Holtec pulled its offering, per the same Inquirer report. Pricing a $10.2 billion IPO into a sector where the two most recent comparable listings are both trading meaningfully underwater is a hard sell to institutional investors, whatever the demand story for nuclear power looks like long term.
What the S-1 Shows About Holtec's Actual Business
On a 2025 pro forma basis, Holtec disclosed revenue of $893.4 million, operating income of $140.2 million, and net income of $217.0 million. The pro forma revenue jump reflects a change in how Holtec consolidates its business segments for the filing rather than a sudden increase in underlying activity, so it is not a clean year-over-year growth comparison.
| Metric | Figure | As of / Note |
|---|---|---|
| 2025 pro forma revenue | $893.4M | Reflects consolidation change, not organic growth |
| 2025 pro forma operating income | $140.2M | ~15.7% margin |
| 2025 pro forma net income | $217.0M | Includes non-operating items |
| Nuclear Power Division backlog | ~$10.57B | As of June 30, 2026 โ contracted, long-dated |
| Palisades segment backlog | ~$10.4B | As of March 31, 2026 |
| SMR-300 program revenue | ~$0 today | Future revenue from sales, licensing, milestones |
| Granted patents | 200+ | As of June 30, 2026 |
| Reactors served (products/services) | 150+ | Worldwide, per S-1 |
Sources: Holtec Nuclear Corp S-1 and S-1/A filings via SEC EDGAR, filed July 10, 2026 and amended through September 2026.
Where I Could Be Wrong
A postponed IPO is not a canceled one, and Holtec explicitly said it would keep evaluating timing โ companies that pull an offering for "market conditions" often return within two to six months once sentiment shifts, sometimes at a lower valuation and sometimes at the same one if the underlying backlog holds up. The $10.57 billion Nuclear Power Division backlog and the existing 150-plus-reactor service business are real, contracted revenue streams that do not depend on SMR-300 execution or Palisades' restart succeeding โ so the case for Holtec eventually pricing this deal, or a smaller version of it, is stronger than the case for X-Energy or Standard Nuclear's current stock prices reflecting where the whole nuclear-services sector ends up. It's also possible the data-center demand story CEO Krishna Singh cited proves temporary rather than structural, in which case the "bad timing" explanation ages better than a read that treats this as evidence nuclear-sector public-market appetite has permanently soured.
What This Means for the Nuclear IPO Wave
Holtec's postponement is a real data point against the narrative that AI-driven data-center power demand guarantees nuclear and SMR companies a smooth run to public markets. Two of 2026's nuclear listings are trading well below issue price, and now the largest disclosed deal in the pipeline, per its own S-1 terms, has been pulled rather than priced into that weakness. For the rest of 2026's IPO pipeline, it is a reminder that a hot narrative and a large contracted backlog are not enough on their own โ aftermarket performance from the first movers in a sector sets the price umbrella for everyone who files after them, and right now that umbrella is pointing down for nuclear.
For investors and founders tracking the SMR and nuclear-services space specifically, the more durable signal in Holtec's S-1 is probably the backlog, not the IPO timing: $10.57 billion in contracted Nuclear Power Division revenue and a 150-plus-reactor installed base is a real business regardless of when, or whether, Holtec returns to the public markets.
Two nuclear IPOs trading underwater, one large deal pulled days before pricing.
Holtec's $10.2B question isn't whether the backlog is real โ it's whether public markets will pay for it yet.
Track the 2026 listing calendar on our tech IPO calendar at Value Add VC. Originally published in the Trace Cohen newsletter.
Latest from the Pulse
Get VC data most people never see
โ 100% free
Weekly benchmarks, valuations, and fund data. Join 5,000+ investors. No spam.